Literature DB >> 2710173

Effect of the time of administration of calcium acetate on phosphorus binding.

L R Schiller1, C A Santa Ana, M S Sheikh, M Emmett, J S Fordtran.   

Abstract

Phosphorus binders are given to patients with renal failure to increase gastrointestinal excretion of phosphorus. To determine the relative importance of the binding of dietary as compared with endogenous phosphorus and to determine the optimal dose schedule, we gave either 4.4 g of calcium acetate (25 mmol of calcium) or a placebo to six normal subjects on each of seven different schedules in a randomized sequence. The net gastrointestinal balance of phosphorus and calcium was determined by a one-day lavage technique. After a meal containing approximately 12 mmol of phosphorus, the mean phosphorus absorption (+/- SE) measured 9.17 +/- 0.36 mmol (78 percent) with placebo but decreased to 3.81 +/- 0.58 mmol (31 percent) when calcium acetate was given immediately before the meal (representing binding of 5.36 +/- 0.77 mmol of phosphorus). Similar binding was observed when calcium acetate was given immediately after the meal and when half the dose was given before and half after the meal. In contrast, when calcium acetate was given two hours after the meal or while the subject was fasting, phosphorus binding was reduced to 2.00 +/- 0.52 mmol and 1.81 +/- 0.84 mmol, respectively. Calcium absorption from calcium acetate averaged 21 +/- 1 percent when the binder was given with a meal; absorption from calcium acetate averaged 40 +/- 4 percent when the binder was given while the subject was fasting. We conclude that calcium acetate increases fecal excretion of phosphorus by binding both dietary and endogenous phosphorus, but the binding of dietary phosphorus is quantitatively much more important. For the most efficient phosphorus binding, calcium (and presumably other phosphorus-binding cations) should be given with meals.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2710173     DOI: 10.1056/NEJM198904273201703

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  13 in total

Review 1.  Hyperphosphataemia in renal failure: causes, consequences and current management.

Authors:  Fouad Albaaj; Alastair Hutchison
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 2.  Nephrology, dialysis and transplantation.

Authors:  K Farrington; P Sweny
Journal:  Postgrad Med J       Date:  1990-07       Impact factor: 2.401

Review 3.  Phosphate binders in patients with chronic kidney disease.

Authors:  Samuel Chan; Kenneth Au; Ross S Francis; David W Mudge; David W Johnson; Peter I Pillans
Journal:  Aust Prescr       Date:  2017-02-01

4.  Patiromer-an Oral Calcium-Loaded Potassium Binder: Kalirrhea with Calciuresis.

Authors:  Michael Emmett; Ankit Mehta
Journal:  Clin J Am Soc Nephrol       Date:  2016-09-27       Impact factor: 8.237

5.  Contribution of food additives to sodium and phosphorus content of diets rich in processed foods.

Authors:  Anna Carrigan; Andrew Klinger; Suzanne S Choquette; Alexandra Luzuriaga-McPherson; Emmy K Bell; Betty Darnell; Orlando M Gutiérrez
Journal:  J Ren Nutr       Date:  2014-01       Impact factor: 3.655

6.  Calcium acetate versus calcium carbonate as oral phosphate binder in pediatric and adolescent hemodialysis patients.

Authors:  M Wallot; K E Bonzel; A Winter; B Geörger; B Lettgen; M Bald
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

7.  Calcium carbonate as a phosphate binder in dialysis patients: evaluation of an enteric-coated preparation and effect of additional aluminium hydroxide on hyperaluminaemia.

Authors:  T H Ittel; C Schäfer; H Schmitt; U Gladziwa; H G Sieberth
Journal:  Klin Wochenschr       Date:  1991-01-22

8.  Association of a reduction in central obesity and phosphorus intake with changes in urinary albumin excretion: the PREMIER study.

Authors:  Alex Chang; Bryan C Batch; Heather L McGuire; William M Vollmer; Laura P Svetkey; Crystal C Tyson; Anawin Sanguankeo; Cheryl Anderson; Jessica Houston; Lawrence J Appel
Journal:  Am J Kidney Dis       Date:  2013-06-28       Impact factor: 8.860

9.  Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines.

Authors:  G Klaus; A Watson; A Edefonti; M Fischbach; K Rönnholm; F Schaefer; E Simkova; C J Stefanidis; V Strazdins; J Vande Walle; C Schröder; A Zurowska; M Ekim
Journal:  Pediatr Nephrol       Date:  2005-10-25       Impact factor: 3.714

10.  Hypercalcemia, metabolic alkalosis and renal failure secondary to calcium bicarbonate intake for osteoporosis prevention--'modern' milk alkali syndrome: a case report.

Authors:  Alain Waked; Abdallah Geara; Badiaa El-Imad
Journal:  Cases J       Date:  2009-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.